New Insights into the Genetic Etiology of Alzheimer's Disease and Related Dementias

Characterization of the genetic landscape of Alzheimer's disease (AD) and related dementias (ADD) provides a unique opportunity for a better understanding of the associated pathophysiological processes. We performed a two-stage genome-wide association study totaling 111,326 clinically diagnosed/'proxy' AD cases and 677,663 controls. We found 75 risk loci, of which 42 were new at the time of analysis. Pathway enrichment analyses confirmed the involvement of amyloid/tau pathways and highlighted microglia implication. Gene prioritization in the new loci identified 31 genes that were suggestive of new genetically associated processes, including the tumor necrosis factor alpha pathway through the linear ubiquitin chain assembly complex. We also built a new genetic risk score associated with the risk of future AD/dementia or progression from mild cognitive impairment to AD/dementia. The improvement in prediction led to a 1.6- to 1.9-fold increase in AD risk from the lowest to the highest decile, in addition to effects of age and the APOE ε4 allele.

Citing Articles

Investigation of the role of miRNA variants in neurodegenerative brain diseases.

Frydas A, Cacace R, van der Zee J, Van Broeckhoven C, Wauters E Front Genet. 2025; 16:1506169.

PMID: 40078479 PMC: 11897046. DOI: 10.3389/fgene.2025.1506169.

Machine Learning Methods for Classifying Multiple Sclerosis and Alzheimer's Disease Using Genomic Data.

Arnal Segura M, Bini G, Krithara A, Paliouras G, Tartaglia G Int J Mol Sci. 2025; 26(5).

PMID: 40076709 PMC: 11900513. DOI: 10.3390/ijms26052085.

Phagocytosis-driven neurodegeneration through opposing roles of an ABC transporter in neurons and phagocytes.

Chen X, Wang B, Sarkar A, Huang Z, Ruiz N, Yeung A Sci Adv. 2025; 11(11):eadr5448.

PMID: 40073145 PMC: 11900885. DOI: 10.1126/sciadv.adr5448.

Antagonizing Il10 and Il4 signaling via intracerebral decoy receptor expression attenuates Aβ accumulation.

Koller E, McFarland K, Angelle C, Howard J, Ryu D, Dillon K Acta Neuropathol Commun. 2025; 13(1):51.

PMID: 40055831 PMC: 11887169. DOI: 10.1186/s40478-025-01968-3.

TREM2 risk variants and associated endophenotypes in alzheimer's disease.

Dijkstra J, Vermunt L, Venkatraghavan V, Ozhegov G, Coomans E, Ossenkoppele R Alzheimers Res Ther. 2025; 17(1):57.

PMID: 40051009 PMC: 11883996. DOI: 10.1186/s13195-025-01700-2.

References

Gatz M, Reynolds C, Fratiglioni L, Johansson B, Mortimer J, Berg S . Role of genes and environments for explaining Alzheimer disease. Arch Gen Psychiatry. 2006; 63(2):168-74. DOI: 10.1001/archpsyc.63.2.168. View

Bellenguez C, Grenier-Boley B, Lambert J . Genetics of Alzheimer's disease: where we are, and where we are going. Curr Opin Neurobiol. 2019; 61:40-48. DOI: 10.1016/j.conb.2019.11.024. View

Jansen I, Savage J, Watanabe K, Bryois J, Williams D, Steinberg S . Genome-wide meta-analysis identifies new loci and functional pathways influencing Alzheimer's disease risk. Nat Genet. 2019; 51(3):404-413. PMC: 6836675. DOI: 10.1038/s41588-018-0311-9. View

Chang C, Chow C, Tellier L, Vattikuti S, Purcell S, Lee J . Second-generation PLINK: rising to the challenge of larger and richer datasets. Gigascience. 2015; 4:7. PMC: 4342193. DOI: 10.1186/s13742-015-0047-8. View

Kunkle B, Grenier-Boley B, Sims R, Bis J, Damotte V, Naj A . Genetic meta-analysis of diagnosed Alzheimer's disease identifies new risk loci and implicates Aβ, tau, immunity and lipid processing. Nat Genet. 2019; 51(3):414-430. PMC: 6463297. DOI: 10.1038/s41588-019-0358-2. View

Lambert J, Ibrahim-Verbaas C, Harold D, Naj A, Sims R, Bellenguez C . Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer's disease. Nat Genet. 2013; 45(12):1452-8. PMC: 3896259. DOI: 10.1038/ng.2802. View

Liu J, Erlich Y, Pickrell J . Case-control association mapping by proxy using family history of disease. Nat Genet. 2017; 49(3):325-331. DOI: 10.1038/ng.3766. View

Marioni R, Harris S, Zhang Q, McRae A, Hagenaars S, Hill W . GWAS on family history of Alzheimer's disease. Transl Psychiatry. 2018; 8(1):99. PMC: 5959890. DOI: 10.1038/s41398-018-0150-6. View

Sims R, van der Lee S, Naj A, Bellenguez C, Badarinarayan N, Jakobsdottir J . Rare coding variants in PLCG2, ABI3, and TREM2 implicate microglial-mediated innate immunity in Alzheimer's disease. Nat Genet. 2017; 49(9):1373-1384. PMC: 5669039. DOI: 10.1038/ng.3916. View

10.

Jun G, Ibrahim-Verbaas C, Vronskaya M, Lambert J, Chung J, Naj A . A novel Alzheimer disease locus located near the gene encoding tau protein. Mol Psychiatry. 2015; 21(1):108-17. PMC: 4573764. DOI: 10.1038/mp.2015.23. View

11.

Schwartzentruber J, Cooper S, Liu J, Barrio-Hernandez I, Bello E, Kumasaka N . Genome-wide meta-analysis, fine-mapping and integrative prioritization implicate new Alzheimer's disease risk genes. Nat Genet. 2021; 53(3):392-402. PMC: 7610386. DOI: 10.1038/s41588-020-00776-w. View

12.

de Rojas I, Moreno-Grau S, Tesi N, Grenier-Boley B, Andrade V, Jansen I . Common variants in Alzheimer's disease and risk stratification by polygenic risk scores. Nat Commun. 2021; 12(1):3417. PMC: 8184987. DOI: 10.1038/s41467-021-22491-8. View

13.

Wightman D, Jansen I, Savage J, Shadrin A, Bahrami S, Holland D . A genome-wide association study with 1,126,563 individuals identifies new risk loci for Alzheimer's disease. Nat Genet. 2021; 53(9):1276-1282. PMC: 10243600. DOI: 10.1038/s41588-021-00921-z. View

14.

Skene N, Bryois J, Bakken T, Breen G, Crowley J, Gaspar H . Genetic identification of brain cell types underlying schizophrenia. Nat Genet. 2018; 50(6):825-833. PMC: 6477180. DOI: 10.1038/s41588-018-0129-5. View

15.

de Leeuw C, Stringer S, Dekkers I, Heskes T, Posthuma D . Conditional and interaction gene-set analysis reveals novel functional pathways for blood pressure. Nat Commun. 2018; 9(1):3768. PMC: 6138636. DOI: 10.1038/s41467-018-06022-6. View

16.

Haass C, Kaether C, Thinakaran G, Sisodia S . Trafficking and proteolytic processing of APP. Cold Spring Harb Perspect Med. 2012; 2(5):a006270. PMC: 3331683. DOI: 10.1101/cshperspect.a006270. View

17.

Chapuis J, Flaig A, Grenier-Boley B, Eysert F, Pottiez V, Deloison G . Genome-wide, high-content siRNA screening identifies the Alzheimer's genetic risk factor FERMT2 as a major modulator of APP metabolism. Acta Neuropathol. 2016; 133(6):955-966. PMC: 5427165. DOI: 10.1007/s00401-016-1652-z. View

18.

Cleynen A, Szalat R, Kemal Samur M, Robiou du Pont S, Buisson L, Boyle E . Expressed fusion gene landscape and its impact in multiple myeloma. Nat Commun. 2017; 8(1):1893. PMC: 5711960. DOI: 10.1038/s41467-017-00638-w. View

19.

Szklarczyk D, Gable A, Lyon D, Junge A, Wyder S, Huerta-Cepas J . STRING v11: protein-protein association networks with increased coverage, supporting functional discovery in genome-wide experimental datasets. Nucleic Acids Res. 2018; 47(D1):D607-D613. PMC: 6323986. DOI: 10.1093/nar/gky1131. View

20.

Spit M, Rieser E, Walczak H . Linear ubiquitination at a glance. J Cell Sci. 2019; 132(2). DOI: 10.1242/jcs.208512. View